Skip to main content
Log in

Pharmacokinetics and metabolism of digoxigenin-mono-digitoxoside in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

3H-digoxigenin-mono-digitoxoside 1 mg was swallowed by 6 healthy subjects. Maximum plasma levels of radioactivity were reached within 1–2 h; in two subjects there was a second peak at 8–12 h. No definite half lives could be determined because the falls in plasma activity were not exponential. 3.9–39% and 34.5–76.6% of the dose were eliminated in urine and faeces, respectively. 75–90% of the total radioactivity in plasma was CHCl3-insoluble, there was less of this fraction in urine, and the major portion in faceces was CHCl3-soluble. The CHCl3-insoluble fraction in urine was separated into 3 components by chromatography on an Al2O3-column and consisted mainly of conjugates of the monoglycoside and 3-epidigoxigenin. TLC-separation of the lipophilic fraction in urine also revealed unchanged monoglycoside and 3-epidigoxigenin, as well as traces of digoxigenin, 3-ketodigoxigenin and 2 unidentified, more polar metabolites. In faeces, the main excretion product was the unchanged compound, and traces of digoxigenin, 3-epidigoxigenin, 3-ketodigoxigenin and one of the more polar metabolites detected in urine. Two patients with surgical T-tube bile-duct drainage showed significantly greater biliary excretion after oral administration of the digoxigenin-mono-digitoxoside than after digoxin. Almost all the radioactivity excreted in bile was CHCl3-insoluble and the monoglycoside was shown to be the only conjugation partner present by incubation with arylsulfatase and β-glucuronidase. The results show that digoxigenin-mono-digitoxoside has such a rapid metabolic inactivation and biliary clearance in man that it is unlikely to be of any therapeutic value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abshagen, U., Bergmann, K.V., Rietbrock, N.: Evaluation of the enterohepatic circulation after3H-digoxin administration in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol.275, 1–10 (1972)

    Google Scholar 

  • Abshagen, U., Rietbrock, N.: Metabolism of digoxigenin, digoxigenin-mono-digitoxoside and digoxigenin-bis-digitoxoside in rats. Naunyn-Schmiedeberg's Arch. Pharmacol.276, 157–166 (1973)

    Google Scholar 

  • Abshagen, U., Rennekamp, H.: Formation and disposition of bis- and monoglycosides after3H-4′″-methyldigoxin administration in man. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl. 279, R 45 (1973)

  • Barlow, J.J., Kellie, A.E.: A quantitative method for the chromatographic separation of 17-oxo-steroid sulfates from 17-oxo-steroid glucuronides: with observations on the behaviour of conjugated corticosteroids on the same system. Biochem. J.71, 86–91 (1959)

    Google Scholar 

  • Böttcher, H., Lüllmann, H., Proppe, D.: Comparison of digoxin with some digitoxin metabolites on cat heart lung preparation. Europ. J. Pharmacol.22, 109–111 (1973)

    Google Scholar 

  • Dengler, H.J., Bodem, G., Wirth, K.: Pharmakokinetische Untersuchungen mit3H-Digoxin und3H-Lanatosid beim Menschen. Arzneimittel-Forsch.23, 64–74 (1973)

    Google Scholar 

  • Doherty, J.E., Flanigan, W.J., Murphy, M.L., Bulloch, R. T., Dalrymple, G.L., Beard, O.W., Perkins, W.H.: Tritiated digoxin, XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers. Circulation42, 867–873 (1970)

    Google Scholar 

  • Herrmann, I., Repke, K.: Konjugation von Cardenolidgeninen mit Schwefelsäure oder Glucuronsäure. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.248, 370–386 (1964)

    Google Scholar 

  • Kaiser, F.: Die papierchromatographische Trennung von Herzgiftglycosiden. Chem. Ber.88, 556–563 (1955)

    Google Scholar 

  • Katzung, B.G., Meyers, F.H.: Excretion of radioactive digitoxin by the dog. J. Pharmacol. exp. Ther.149, 257–262 (1965)

    Google Scholar 

  • Lauterbach, F., Repke, K.: Die fermentative Abspaltung von D-Digitoxose, D-Cymarose und L-Thevetose aus Herzglycosiden durch Leberschnitte. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.239, 196–218 (1960)

    Google Scholar 

  • Lüllmann, H., Peters, T.: The cardioactivity of digitoxin metabolites. Europ. J. Pharmacol.14, 204–205 (1971)

    Google Scholar 

  • Repke, K.: Die Bis- und Monodigitoxoside des Digitoxigenins und Digoxigenins: Metaboliten des Digitoxins. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.237, 155–170 (1959)

    Google Scholar 

  • Repke, K.: Stoffwechsel und Wirkung von Digitalisglycosiden. Öst. Apoth.-Ztg.24, 515–522 (1970)

    Google Scholar 

  • Schubert, D., Hobe, G.: Über das chromatographische Verhalten der Phosphorsäureester von Dehydroepiandrosteron und Testosteron. Hoppe-Seylers Z. physiol. Chem.323, 264–269 (1961)

    Google Scholar 

  • Talcott, R.E., Stohs, S.J., El-Olemy, M. M.: Metabolites and some characteristics of the metabolism of3H-digoxigenin by rat liver homogenates. Biochem. Pharmacol.21, 2001–2006 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by the Deutsche Forschungsgemeinschaft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuhlmann, J., Abshagen, U. & Rietbrock, N. Pharmacokinetics and metabolism of digoxigenin-mono-digitoxoside in man. Eur J Clin Pharmacol 7, 87–94 (1974). https://doi.org/10.1007/BF00561320

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561320

Key words

Navigation